Influenza virus genetics

被引:73
作者
Brown, EG [1 ]
机构
[1] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada
关键词
antiviral; genetics; influenza virus;
D O I
10.1016/S0753-3322(00)89026-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Significant progress has been made in understanding the process of influenza A virus replication in cell culture; however, much less is known about the genetic control of virus-host interactions in disease. This review provides an overview of the genetic analysis of influenza virus biology. The functional map of the individual genes of influenza A virus is presented as well as the status of our current understanding of pathogenesis. Influenza has a segmented genome so it is possible to obtain reassortants that contain novel combinations of genome segments derived from different viruses. This is a very useful genetic tool and is also an important aspect of influenza evolution and biology. Human influenza viruses originate from avian strains of influenza virus so that influenza infection is at its basis a zoonosis. Influenza virus strains are host-restricted, however, and avian strains must be adapted to the human host. So questions of host-range and interaction with host factors are important determinants of the ability of influenza virus to cause disease in humans. Host-range is restricted primarily due to host-specific interactions of the ribonucleocapsid and the viral receptor. There are two classes of drugs for inhibiting influenza infection, amantadine HCl and neuraminidase inhibitors. The mode of action and basis for resistance to these drugs are presented. Prospective targets for antiviral therapy are also discussed. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:196 / 209
页数:14
相关论文
共 54 条
[1]   Genetic analysis reveals that both haemagglutinin and neuraminidase determine the sensitivity of naturally occurring avian influenza viruses to zanamivir in vitro [J].
Baigent, SJ ;
Bethell, RC ;
McCauley, JW .
VIROLOGY, 1999, 263 (02) :323-338
[2]   Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140 [J].
Bantia, S ;
Ghate, AA ;
Ananth, SL ;
Babu, YS ;
Air, GM ;
Walsh, GM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :801-807
[3]   INCREASED VIRULENCE OF A MOUSE-ADAPTED VARIANT OF INFLUENZA A/FM/1/47 VIRUS IS CONTROLLED BY MUTATIONS IN GENOME SEGMENTS 4, 5, 7, AND 8 [J].
BROWN, EG .
JOURNAL OF VIROLOGY, 1990, 64 (09) :4523-4533
[4]   Genetic analysis of mouse-adapted influenza A virus identifies roles for the NA, PB1, and PB2 genes in virulence [J].
Brown, EG ;
Bailly, JE .
VIRUS RESEARCH, 1999, 61 (01) :63-76
[5]   New approaches to influenza chemotherapy - Neuraminidase inhibitors [J].
Calfee, DP ;
Hayden, FG .
DRUGS, 1998, 56 (04) :537-553
[6]   Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery [J].
Chen, ZY ;
Li, YZ ;
Krug, RM .
EMBO JOURNAL, 1999, 18 (08) :2273-2283
[7]  
Colman P.M., 1989, INFLUENZA VIRUSES, P175
[8]  
CROSBY AW, 1994, AM FORGOTTEN PANDEMI, P3
[9]   Modulation of nuclear localization of the influenza virus nucleoprotein through interaction with actin filaments [J].
Digard, P ;
Elton, D ;
Bishop, K ;
Medcalf, E ;
Weeds, A ;
Pope, B .
JOURNAL OF VIROLOGY, 1999, 73 (03) :2222-2231
[10]   Zanamivir - A review of its use in influenza [J].
Dunn, CJ ;
Goa, KL .
DRUGS, 1999, 58 (04) :761-784